CoChat
Sign Up
Cited by 181

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Enforced Expression of the GATA-2 Transcription Factor Blocks Normal Hematopoiesis

Persons, Derek A., Allay, James A., Allay, Esther R., Ashmun, Richard A., Orlic, Donald, Jane, Stephen M., Cunningham, John M., Nienhuis, Arthur W.·1999·Blood
DOI 10.1182/blood.v93.2.488
Open this paper in CoChat — free account

Abstract

The zinc finger transcription factor GATA-2 is highly expressed in immature hematopoietic cells and declines with blood cell maturation. To investigate its role in normal adult hematopoiesis, a bicistronic retroviral vector encoding GATA-2 and the green fluorescent protein (GFP) was used to maintain the high levels of GATA-2 that are normally present in primitive hematopoietic cells. Coexpression of the GFP marker facilitated identification and quantitation of vector-expressing cells. Bone marrow cells transduced with the GATA-2 vector expressed GFP as judged by flow cytometry and GATA-2 as assessed by immunoblot analysis. A 50% to 80% reduction in hematopoietic progenitor-derived colony formation was observed with GATA-2/GFP-transduced marrow, compared with marrow transduced with a GFP-containing vector lacking the GATA-2 cDNA. Culture of purified populations of GATA-2/GFP-expressing and nonexpressing cells confirmed a specific ablation of the colony-forming ability of GATA-2/GFP-expressing progenitor cells. Similarly, loss of spleen colony-forming ability was observed for GATA-2/GFP-expressing bone marrow cells. Despite enforced GATA-2 expression, marrow cells remained viable and were negative in assays to evaluate apoptosis. Although efficient transduction of primitive Sca-1+Lin- cells was observed with the GATA-2/GFP vector, GATA-2/GFP-expressing stem cells failed to substantially contribute to the multilineage hematopoietic reconstitution of transplanted mice. Additionally, mice transplanted with purified, GATA-2/GFP-expressing cells showed post-transplant cytopenias and decreased numbers of total and gene-modified bone marrow Sca-1+ Lin−cells. Although Sca-1+ Lin− bone marrow cells expressing the GATA-2/GFP vector were detected after transplantation, no appreciable expansion in their numbers occurred. In contrast, control GFP-expressing Sca-1+Lin− cells expanded at least 40-fold after transplantation. Thus, enforced expression of GATA-2 in pluripotent hematopoietic cells blocked both their amplification and differentiation. There appears to be a critical dose-dependent effect of GATA-2 on blood cell differentiation in that downregulation of GATA-2 expression is necessary for stem cells to contribute to hematopoiesis in vivo.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood.v93.2.488

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 37

  1. Yamamoto, 1990, Activity and tissue-specific expression of the transcription factor NF-E1 multigene family., Genes Dev, 4, 1650, 10.1101/gad.4.10.1650 · DOI
  2. Orkin, 1992, GATA-binding transcription factors in hematopoietic cells., Blood, 80, 575, 10.1182/blood.V80.3.575.575 · DOI · Paper page
  3. Trainor, 1996, A palindromic regulatory site within vertebrate GATA-1 promoters requires both zinc fingers of the GATA-1 DNA-binding domain for high-affinity interaction., Mol Cell Biol, 16, 2238, 10.1128/MCB.16.5.2238 · DOI · Paper page
  4. Tsang, 1997, FOG, a multiple zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation., Cell, 90, 109, 10.1016/S0092-8674(00)80318-9 · DOI · Paper page
  5. Evans, 1989, The erythroid-specific transcription factor eryf1: A new finger protein., Cell, 58, 877, 10.1016/0092-8674(89)90940-9 · DOI
  6. Tsai, 1989, Cloning of cDNA for the major DNA binding protein of the erythroid lineage through expression in mammalian cells., Nature, 339, 446, 10.1038/339446a0 · DOI
  7. Fujiwara, 1996, Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1., Proc Natl Acad Sci USA, 93, 12355, 10.1073/pnas.93.22.12355 · DOI · Paper page
  8. Leonard, 1993, Dynamics of GATA transcription factor expression during erythroid differentiation., Blood, 82, 1071, 10.1182/blood.V82.4.1071.1071 · DOI
  9. Visvader, 1993, Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression., Blood, 82, 1493, 10.1182/blood.V82.5.1493.1493 · DOI
  10. Dorfman, 1992, Human transcription factor GATA-2: Evidence for regulation of preproendothelin-1 gene expression in endothelial cells., J Biol Chem, 267, 1279, 10.1016/S0021-9258(18)48426-8 · DOI
  11. Tomoko, 1996, Abundant expression of transcription factor GATA-2 in proliferating but not in differentiated mast cells in tissues of mice: Demonstration by in situ hybridization., Blood, 87, 993, 10.1182/blood.V87.3.993.bloodjournal873993 · DOI
  12. Orlic, 1995, Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7., Proc Natl Acad Sci USA, 92, 4601, 10.1073/pnas.92.10.4601 · DOI
  13. Tsai, 1994, An early haematopoietic defect in mice lacking the transcription factor GATA-2., Nature, 371, 221, 10.1038/371221a0 · DOI · Paper page
  14. Tsai, 1997, Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation., Blood, 89, 3636, 10.1182/blood.V89.10.3636 · DOI
  15. Pandolfi, 1995, Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis., Nat Genet, 11, 40, 10.1038/ng0995-40 · DOI
  16. Ting, 1996, Transcription factor GATA-3 is required for development of the T-cell lineage., Nature, 384, 474, 10.1038/384474a0 · DOI
  17. Cunningham, 1996, Hemoglobin switching and fetal hemoglobin reactivation., Semin Hematol, 33, 9
  18. Briegel, 1993, Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner., Genes Dev, 7, 1097, 10.1101/gad.7.6.1097 · DOI
  19. Persons, 1997, Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo., Blood, 90, 1777, 10.1182/blood.V90.5.1777 · DOI
  20. Markowitz, 1998, A safe packaging line for gene transfer: Separating viral genes on two different plasmids., J Virol, 62, 1120, 10.1128/JVI.62.4.1120-1124.1988 · DOI
  21. Dubridge, 1987, Analysis of mutation in human cells by using an Epstein Barr virus shuttle system., Mol Cell Biol, 7, 379, 10.1128/MCB.7.1.379 · DOI
  22. Hawley, 1994, Versatile retroviral vectors for potential use in gene therapy., Gene Ther, 1, 136
  23. Migita, 1995, Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors., Proc Natl Acad Sci USA, 92, 12075, 10.1073/pnas.92.26.12075 · DOI
  24. Persons, 1998, An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene., Blood Cells Mol Dis, 24, 167, 10.1006/bcmd.1998.0184 · DOI
  25. Krishan, 1975, Rapid flow cytometric analysis of mammalian cell cycle by propidium iodide staining., J Cell Biol, 66, 188, 10.1083/jcb.66.1.188 · DOI
  26. Gorczya, 1993, Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays., Cancer Res, 53, 1945
  27. Inaba, 1996, Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor., Nature, 382, 541, 10.1038/382541a0 · DOI
  28. Whitney, 1978, Simplified typing of mouse hemoglobins (Hbb) phenotypes using cystamine., Biochem Genet, 16, 667, 10.1007/BF00484723 · DOI
  29. Spangrude, 1988, Purification and characterization of mouse hematopoietic stem cells., Science, 241, 58, 10.1126/science.2898810 · DOI
  30. Hawley, 1992, Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus., J Exp Med, 176, 1149, 10.1084/jem.176.4.1149 · DOI
  31. van der Loo, 1995, Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors., Blood, 85, 2598, 10.1182/blood.V85.9.2598.bloodjournal8592598 · DOI
  32. Farina, 1995, Dysregulated expression of GATA-1 following retrovirus-mediated gene transfer into murine hematopoietic stem cells increases erythropoiesis., Blood, 86, 4124, 10.1182/blood.V86.11.4124.bloodjournal86114124 · DOI
  33. Hawley, 1994, The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors., Oncogene, 9, 1
  34. Kamesaki, 1996, TPA-induced arrest of erythroid differentiation is coupled with downregulation of GATA-1 and upregulation of GATA-2 in an erythroid cell line SAM-1., Blood, 87, 999, 10.1182/blood.V87.3.999.bloodjournal873999 · DOI
  35. Hodgson, 1979, Properties of hematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell?, Nature, 281, 381, 10.1038/281381a0 · DOI
  36. Lerner, 1990, 5-fluorouracil spares hematopoietic stem cells responsible for long-term repopulation., Exp Hematol, 18, 114
  37. Bradford, 1997, Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment., Exp Hematol, 15, 445

Cited by

Metadata

Authors
Persons, D. A., Allay, J. A., Allay, E. R., Ashmun, R. A., Orlic, D., Jane, S. M., Cunningham, J. M., & Nienhuis, A. W.
Affiliations
From the Division of Experimental Hematology, Department of Hematology/Oncology and the Department of Experimental Oncology, St Jude Children’s Research Hospital, Memphis, TN; and the Hematopoiesis Section, Genetic and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD.
Venue
Blood
Publisher
American Society of Hematology
Published
1999-01-15
Volume
93
Issue
2
Pages
488-499
ISSN
  • 1528-0020
  • 0006-4971
DOI
10.1182/blood.v93.2.488
Cited by
181
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review